Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugAntibioticFirst approved 2005

Doryx Mpc(Doxycycline Hyclate)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$244K

Medicare cost, 2024

Medicare drug plans spent $243,799 on Doryx Mpc (doxycycline hyclate) in 2024, for 244 prescriptions and refills filled by 141 patients. Spending rose 68% from 2023 to 2024. Florida accounts for the most spending ($47,228, 19% of the total).

Medicare cost, 2024

$244K

+67.5% from 2023

Prescriptions

244

$999.18 per claim

Patients

141

119 prescribers

Total spending, 2024

$244K

$1,729.07 per patient

Questions and answers

How much does Medicare spend on Doryx Mpc?

Medicare prescription drug plans paid $244K for Doryx Mpc in 2024, for 244 prescriptions and refills to 141 patients (up 67.5% from 2023). The average cost per claim was $999.18.

Which state spends the most on Doryx Mpc?

Florida had the highest Medicare cost for Doryx Mpc in 2024: $47K for 54 claims, followed by California ($41K).

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Doryx Mpc was $244K in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022317031$37K
202394167101$146K
2024119244141$244K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Mayne Pharma In244$244K

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
2
RxNorm concept IDs
1801138, 1801140, 1801142, 1801144
Application numbers
NDA050795

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube